Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Recurrent Nasopharyngeal Carcinoma”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Testing effectiveness (Phase 2)UnknownNCT00690872
What this trial is testing

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 35
Testing effectiveness (Phase 2)Study completedNCT02795195
What this trial is testing

Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06611826
What this trial is testing

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

Who this might be right for
Nasopharynx Cancer
Zhejiang Cancer Hospital 41
Large-scale testing (Phase 3)Looking for participantsNCT06235203
What this trial is testing

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 154
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129772
What this trial is testing

Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer RecurrentNasopharyngeal Cancinoma (NPC)
The University of Hong Kong 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07528183
What this trial is testing

PD-1 Monoclonal Antibody Combined With Gemcitabine and Cisplatin Followed by Selective Radiotherapy for Unresectable Locally Recurrent NPC

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 86
Testing effectiveness (Phase 2)Study completedNCT00003206
What this trial is testing

Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT03813394
What this trial is testing

Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC

Who this might be right for
Locally Recurrent CancerMetastatic Nasopharyngeal Cancer
National University Hospital, Singapore 48
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Testing effectiveness (Phase 2)UnknownNCT02636231
What this trial is testing

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 96
Large-scale testing (Phase 3)Looking for participantsNCT04136886
What this trial is testing

Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 346
Testing effectiveness (Phase 2)UnknownNCT03130270
What this trial is testing

Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Guilin Medical University, China 29
Large-scale testing (Phase 3)Looking for participantsNCT04453813
What this trial is testing

Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaChemotherapyRadiotherapy+1 more
Sun Yat-sen University 226
Not applicableEnded earlyNCT02388932
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma+25 more
Case Comprehensive Cancer Center 3
Not applicableNot Yet RecruitingNCT07088484
What this trial is testing

Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Fujian Cancer Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01326559
What this trial is testing

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
Hong Kong Nasopharyngeal Cancer Study Group Limited 33
Testing effectiveness (Phase 2)WithdrawnNCT00367718
What this trial is testing

Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Johns Hopkins University
Testing effectiveness (Phase 2)Ended earlyNCT01313390
What this trial is testing

Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University College, London 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06987123
What this trial is testing

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Study completedNCT00040807
What this trial is testing

Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Load More Results